Economic Evaluation of First-Line Treatments for Metastatic Renal Cell Carcinoma: A Cost-Effectiveness Analysis in A Health Resource–Limited Setting

BACKGROUND: To estimate, from the perspective of the Chinese healthcare system, the economic outcomes of five different first-line strategies among patients with metastatic renal cell carcinoma (mRCC). METHODS AND FINDINGS: A decision-analytic model was developed to simulate the lifetime disease cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bin, Dong, Baijun, Xu, Yuejuan, Zhang, Qiang, Shen, Jinfang, Chen, Huafeng, Xue, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297611/
https://www.ncbi.nlm.nih.gov/pubmed/22412884
http://dx.doi.org/10.1371/journal.pone.0032530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297611/
https://www.ncbi.nlm.nih.gov/pubmed/22412884
http://dx.doi.org/10.1371/journal.pone.0032530

Ejemplares similares